Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
作者： Heikki Joensuu , Peter J. Roberts , Maarit Sarlomo-Rikala , Leif C. Andersson , Pekka Tervahartiala
DOI: 10.1056/NEJM200104053441404
关键词:
摘要: Gastrointestinal stromal tumors are a group of mesenchymal neoplasms that arise from precursors of the connective-tissue cells of the gastrointestinal tract. They occur predominantly in …
elsevier.com
sci-hub.se 参考文章(9)
Boudewijn E. C. Plaat, Harry Hollema, Willemina M. Molenaar, Gerben H. Torn Broers, Justin Pijpe, Mirjam F. Mastik, Harald J. Hoekstra, Eva van den Berg, Rik J. Scheper, Winette T. A. van der Graaf, Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins Journal of Clinical Oncology. ,vol. 18, pp. 3211- 3220 ,(2000) , 10.1200/JCO.2000.18.18.3211
Marcia L. Lux, Brian P. Rubin, Tara L. Biase, Chang-Jie Chen, Timothy Maclure, George Demetri, Sheng Xiao, Samuel Singer, Christopher D.M. Fletcher, Jonathan A. Fletcher, KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. American Journal of Pathology. ,vol. 156, pp. 791- 795 ,(2000) , 10.1016/S0002-9440(10)64946-2
Brian J. Druker, Shu Tamura, Elisabeth Buchdunger, Sayuri Ohno, Gerald M. Segal, Shane Fanning, Jürg Zimmermann, Nicholas B. Lydon, Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Medicine. ,vol. 2, pp. 561- 566 ,(1996) , 10.1038/NM0596-561
Markku Miettinen, Maarit Sarlomo-Rikala, Jerzy Lasota, Gastrointestinal stromal tumors: recent advances in understanding of their biology. Human Pathology. ,vol. 30, pp. 1213- 1220 ,(1999) , 10.1016/S0046-8177(99)90040-0
Jerzy Lasota, Marek Jasinski, Maarit Sarlomo-Rikala, Markku Miettinen, Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas American Journal of Pathology. ,vol. 154, pp. 53- 60 ,(1999) , 10.1016/S0002-9440(10)65250-9
Krisztina M. Zsebo, David A. Williams, Edwin N. Geissler, Virginia C. Broudy, Francis H. Martin, Harry L. Atkins, Rou-Yin Hsu, Neal C. Birkett, Kenneth H. Okino, Douglas C. Murdock, Frederick W. Jacobsen, Keith E. Langley, Kent A. Smith, Takashi Takeish, Bruce M. Cattanach, Stephen J. Galli, Sidney V. Suggs, Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor Cell. ,vol. 63, pp. 213- 224 ,(1990) , 10.1016/0092-8674(90)90302-U
S. Hirota, Gain-of-Function Mutations of c-kit in Human Gastrointestinal Stromal Tumors Science. ,vol. 279, pp. 577- 580 ,(1998) , 10.1126/SCIENCE.279.5350.577
M Sarlomo-Rikala, A J Kovatich, M Miettinen, A Barusevicius, CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34 Modern Pathology. ,vol. 11, pp. 728- 734 ,(1998)
Brian J. Druker, Moshe Talpaz, Debra J. Resta, Bin Peng, Elisabeth Buchdunger, John M. Ford, Nicholas B. Lydon, Hagop Kantarjian, Renaud Capdeville, Sayuri Ohno-Jones, Charles L. Sawyers, Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia The New England Journal of Medicine. ,vol. 344, pp. 1031- 1037 ,(2001) , 10.1056/NEJM200104053441401